months. At 24 months a similar proportion of participants had complete data for the different categories but at four months more participants had complete data for inpatient and emergency admissions than outpatient and primary care visits.
Overall, utility data were more complete than cost data. The proportion of participants with data for both costs and utility was somewhat lower than for either variable alone. Single study-based economic evaluation: Describe the effects of sampling uncertainty for the estimated incremental cost and incremental effectiveness parameters, together with the impact of methodological assumptions (such as discount rate, study perspective).
Page 16 Table 3  Characterising  heterogeneity   21 If applicable, report differences in costs, outcomes, or costeffectiveness that can be explained by variations between subgroups of patients with different baseline characteristics or other observed variability in effects that are not reducible by more information. n/a Discussion Study findings, limitations, generalisability, and current knowledge
22
Summarise key study findings and describe how they support the conclusions reached. Discuss limitations and the generalisability of the findings and how the findings fit with current knowledge. Pages 9-11 Other Source of funding 23
Describe how the study was funded and the role of the funder in the identification, design, conduct, and reporting of the analysis.
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